Effects of Haloperidol on Csf Glutamate Levels in Drug-Naive Schizophrenic Patients
dc.contributor.author | Labarca, R. | |
dc.contributor.author | Bustos O., Gonzalo | |
dc.date.accessioned | 2017-04-11T20:51:13Z | |
dc.date.available | 2017-04-11T20:51:13Z | |
dc.date.issued | 1995 | |
dc.identifier.issn | 0920-9964 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/18912 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido parcial | |
dc.relation.isformatof | Schizophrenia Research. Vol. 16, no. 1 (1995), p. [83]-85 | |
dc.revista | Schizophrenia Research | es_ES |
dc.rights | acceso restringido | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.other | Esquizofrenia Ácido glutámico | es_ES |
dc.subject.other | Haloperidol - uso terapéutico | es_ES |
dc.title | Effects of Haloperidol on Csf Glutamate Levels in Drug-Naive Schizophrenic Patients | es_ES |
dc.type | artículo | |
sipa.codpersvinculados | 98496 |